Interaction of Spironolactone With ACE Inhibitors or Angiotensin Receptor Blockers: Analysis of 44 Cases

BMJ
doi 10.1136/bmj.327.7407.147
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Dual Blockade of the Renin-Angiotensin System With Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs)

British Journal of Clinical Pharmacology
Pharmacology
2011English

Angiotensin-Converting Enzyme Inhibitors (ACE-Is) Versus Angiotensin- Receptor Blockers (ARBs): Any Superiority?

Journal of Hypertension- Open Access
2012English

Does the Use of ACE Inhibitors or Angiotensin Receptor Blockers Affect Bone Loss in Older Men?

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2011English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Prevention of Dementia by ACE Inhibitors and Angiotensin Receptor Blockers - Potential but Not Proven

International Journal of Clinical Practice
Medicine
2010English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Should ACE Inhibitors and Angiotensin Receptor Blockers Be Withdrawn in the Current Setting of COVID-19 Infection?

Wits Journal of Clinical Medicine
2020English

Comparison of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors for Glycaemic Regulation

Endocrine Abstracts
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy